Resources from the 5th Atlantic Melanoma Meeting

Subject to speaker permission, presentations will be posted following the conference for a period of 6 months.

Cutaneous Toxicities of Melanoma Therapies | Ashley Sutherland, MD, FRCPC, Assistant Professor, Division of Clinical Dermatology & Cutaneous Science, Department of Medicine, Dalhousie University

Updates in Adjuvant Systemic Treatment Options for Stage II Melanoma, and Surveillance after Curative Intent Treatment | Dawn Armstrong, MD, FRCPC, Clinical Assistant Professor of Oncology (Medical Oncology), Memorial University

Surgeon’s Role in Management of Advanced Melanoma, Including Neoadjuvant Approach and Metastatectomy | Isabelle Deshaies, MD, FRCSC, Clinical Professor, Department of Surgery, Laval University

The Future of Advanced Melanoma Management: Bringing the Bench Back to the Bedside | Sam Saibil, MD, PhD, FRCPC, Staff Oncologist, Princess Margaret Cancer Centre, Assistant Professor, University of Toronto